Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population

Xiaobin Cui(Tongji Hospital), Feng Li(Bengbu Medical College), Wenjie Zhang(Shihezi University), Wei Liu(Second People’s Hospital of Yibin), Wenyi Gu(Qinghai University), Chunxia Liu(Inner Mongolia Agricultural University), Shugang Li(Shihezi University), Yuwen Cao(Shihezi University), Jianming Hu(Shihezi University), Shiying Yu(Dalian Ocean University), Lei Yang(Fudan University), Xianglin Yuan(Tongji Hospital), Lan Yang(Shihezi University), J. A. Pang(University of Queensland), Yunzhao Chen(Beijing Normal University), Xuelian Pang(Shihezi University), Jinfang Jiang(Hohai University)
Gene
August 24, 2013
10.1016/j.gene.2013.08.057
Cited by 43

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
|Molecular Cancer|2019|477
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475